This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leng, P. Articles by Brown, A. J. P. Search for Related Content PubMed PubMed Citation Articles by Leng, P. Articles by Brown, A. J. P.

 Previous Article  |  Next Article 

Journal of Bacteriology, July 2001, p. 4090-4093, Vol. 183, No. 13
0021-9193/01/$04.00+0   DOI: 10.1128/JB.183.13.4090-4093.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Efg1, a Morphogenetic Regulator in Candida albicans, Is a Sequence-Specific DNA Binding Protein

Ping Leng, Philip R. Lee, Hong Wu,^§ and Alistair J. P. Brown^*

Department of Molecular and Cell Biology, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, United Kingdom

Received 2 March 2001/Accepted 10 April 2001

	ABSTRACT

Top Abstract Text References

Efg1 is essential for hyphal development in the human pathogen Candida albicans under most conditions. Efg1 is related to basic helix-loop-helix regulators, and therefore most workers presume that Efg1 is a transcription factor. Here we confirm that Efg1 is a DNA binding protein that can interact specifically with the E box.

	TEXT

Top Abstract Text References

Candida albicans is the major fungal pathogen of humans (19). This fungus causes frequent and recurrent oral and vaginal infections and systemic infections in severely immunocompromised patients. A number of factors are thought to promote establishment and progression of C. albicans infections, including yeast hypha morphogenesis (5, 16, 20). Several signalling pathways appear to activate hyphal development, and one of these pathways is defined by the factor Efg1 (9, 26). Efg1 probably lies on a Ras-cAMP-protein kinase A signalling pathway (5, 9, 10, 24). Mutations that inactivate Efg1 block hyphal development under most experimental conditions in vitro and in vivo (16, 26). For example, C. albicans efg1/efg1 mutants are unable to form hyphae following serum stimulation or pH induction in vitro or in the kidneys of infected animals. However, efg1/efg1 mutants still form hyphae when they are embedded in agar and in some infection models (6, 21). Nevertheless, Efg1 is considered a major morphogenetic regulator in C. albicans (9).

Ernst and coworkers pointed out that Efg1 contains a basic helix-loop-helix (bHLH) domain with significant sequence similarity to the APSES family of proteins (9, 26). Members of this family include morphogenetic regulators from other fungi, such as Sok2 and Phd1 from Saccharomyces cerevisiae, Asm1 from Neurospora crassa, and StuA from Aspergillus nidulans. This bHLH domain, which is characteristic of some transcription factors, is thought to promote dimerization and DNA binding (18, 22). Therefore, it is generally presumed that Efg1 is a transcription factor, and most models of morphogenetic regulation are based on this presumption (5, 9, 26). However, this remains to be confirmed.

Hypha-specific genes carry E-boxes in their promoters. A number of hypha-specific genes have been identified in C. albicans. Several of these genes, such as HWP1, HYR1, ALS3, and ALS8, encode hyphal wall proteins (1, 12, 14, 25). The functions of other genes, such as ECE1 and RBT4, remain obscure (2-4). Activation of some hypha-specific genes depends upon Efg1 but not upon Cph1 (3, 23). Cph1 is a Ste12-like transcription factor which lies on the MAP kinase signalling pathway that regulates C. albicans morphogenesis (13, 15). We tested whether ALS8 and HYR1 are regulated by Efg1 and Cph1 by using an isogenic set of C. albicans strains (Fig. 1). Both mRNAs were induced following serum stimulation in wild-type and cph1/cph1 cells, but they were not induced in efg1/efg1 cells or an efg1/efg1 cph1/cph1 double mutant. Hence, as expected (3, 23), activation of ALS8 and HYR1 was dependent upon Efg1 but not upon Cph1 under these conditions.

View larger version (71K): [in this window] [in a new window]   FIG. 1.   Efg1p is required for HYR1 and ALS8 activation during serum-induced morphogenesis. We performed a Northern analysis with isogenic C. albicans strains grown for 2 h in YPD containing 10% fetal calf serum at 37°C; the strains used were wild-type strain SC5314 (WT) (11), cph1/cph1 strain JKC19 (15), efg1/efg1 strain HLC52 (16), and cph1/cph1 efg1/efg1 strain HLC54 (54). ALS8 and HYR1 blots were exposed for 8 h and 4 days, respectively. Data from one of two replicate experiments are shown.

bHLH transcription factors related to Efg1 are known to bind to the E box (consensus sequence, 5'-CANNTG-3' [18, 22]). Hence, we studied whether the promoter regions of hypha-specific genes contain E boxes by using regulatory sequence analysis tools (27). The ALS3, ALS8, ECE1, HYR1, HWP1, and RBT4 promoters all contain multiple E boxes (Fig. 2), which is consistent with the idea that Efg1 interacts with the E box to regulate expression of these promoters.

View larger version (33K): [in this window] [in a new window]   FIG. 2.   Hypha-specific promoters contain E boxes. The positions of E boxes (5'-CANNTG-3') (stars) are shown in the 5' regions of the ALS8, HYR1 ALS3, HWP1, ECE1 and RBT4 promoters (http://www-sequence.stanford.edu/group/candida). The scale is relative to the first nucleotide of each coding region.

Synthetic Efg1 binds to an E box. To test whether Efg1 can interact with an E box, we made two forms of synthetic Efg1. First, Efg1 was made with the TNT coupled in vitro transcription-translation system (Promega, Southampton, United Kingdom) by using pGEM-EFGI, which contains the PCR-amplified and resequenced EFG1 open reading frame in pGEM11Z (Promega). Second, a maltose binding protein (MBP)-Efg1 fusion was made in Escherichia coli by using pMAL-EFG1 (17), which contains the EFG1 open reading frame cloned into pMAL-c (New England BioLabs, Beverly, Mass.) (8). The levels of expression of MBP-Efg1 were low, apparently because this protein was toxic to E. coli. Nevertheless, the in vitro Efg1 and MBP-Efg1 were the expected sizes (Fig. 3) given the predicted molecular mass of Efg1, 60 kDa (26).

View larger version (46K): [in this window] [in a new window]   FIG. 3.   Production of synthetic Efg1s. (A) In vitro transcription and translation of EFG1: sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel containing [35S]-labelled reaction product. Lane M, markers; lane 1, control reaction with empty pGEM11Z vector; lane 2, reaction with pGEM-EFG1. (B) Synthesis of a MBP-Efg1 fusion protein in E. coli: Coomassie blue-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel containing soluble protein extracts. Lane M, size markers; lane 1, pMAL-c and no IPTG (isopropyl--D-thiogalactopyranoside); lane 2, pMAL-c with IPTG; lane 3, pMAL-EFG1 with IPTG. The positions of MBP (open arrow) and MBP-Efg1 (solid arrow) are indicated on the right.

Both synthetic Efg1s were used in gel shift experiments (7) to test whether they interacted specifically with E box-containing DNA fragments. Both Efg1s formed complexes with a 90-bp region of the ALS8 promoter that contains an E box (Fig. 4A) and an E box-containing oligonucleotide (Fig. 4B). These complexes were competed out by E box-containing DNA molecules but not by a control oligonucleotide lacking an E box. Furthermore, the complexes were not formed by control extracts lacking Efg1. Therefore, Efg1 is a sequence-specific DNA binding protein capable of binding the E box.

View larger version (73K): [in this window] [in a new window]   FIG. 4.   Synthetic Efg1s interact specifically with the E box in vitro. (A) Gel shift assays in which an E box-containing fragment from the ALS8 promoter (196 to 106) was used. (B) Gel shift assay in which an E box-containing oligonucleotide was used. The extracts used included a control in vitro transcription and translation extract lacking EFG1 (iv), an analogous extract containing EFG1 (iv Efg1p), a control E. coli extract containing the empty MBP expression plasmid (MBP), and an analogous extract containing the MBP-EFG1 fusion plasmid (MBP-Efg1p) (Fig. 3). The probes and competitors used were an ALS8 promoter fragment (F) (196 to 106), an E box-containing oligonucleotide (E) (5'-AGAGATGCATTTGCTAGAGATGCATTTGCTAGACTT), and a control oligonucleotide lacking E boxes (C) (5'-AGAGATGTGCCGATTAGAGATGTGCCGATTAGACTT).

A hypha-specific promoter forms an Efg1-dependent complex. We then tested whether a hypha-specific promoter is able to form Efg1-dependent complexes with C. albicans cell extracts. A 90-bp ALS8 promoter fragment, which contained an E box, formed sequence-specific complexes with wild-type extracts (Fig. 5A). This fragment formed similar complexes with cell extracts prepared from yeast or hyphal cells (data not shown). Formation of the largest of these complexes was inhibited by inactivation of Efg1 but not by inactivation of Cph1. Therefore, the E box-containing region of the ALS8 promoter formed an Efg1-dependent complex.

View larger version (66K): [in this window] [in a new window]   FIG. 5.   E box region from the ALS8 promoter forms Efg1-dependent complexes with C. albicans extracts. Gel shift assays were performed with an E box-containing fragment from the ALS8 promoter (196 to 106). (A) Complexes formed with cell extracts from wild-type C. albicans strain SC5314 and no competitor () a nonspecific competitor (N), or a specific competitor (S) (10-fold excess and then 20-fold excess of unlabelled E box fragment). (B) Cell extracts from wild-type strain SC5314, cph1/cph1 strain JKC19, and efg1/efg1 strain HLC52. The positions of sequence-specific Efg1-dependent complexes (solid arrow) and sequence-specific Efg1p-independent complexes (open arrow) are indicated on the left. The experiments were performed with cell extracts prepared from yeast cells growing on YPD at 25°C. Similar complexes were formed with extracts prepared from cells growing on YPD containing 10% serum at 37°C (data not shown).

The specificity of this interaction was examined further by testing whether other fragments of the ALS8 promoter, which lacked an E box, were capable of forming this Efg1-dependent complex. The following fragments were examined by using extracts prepared from wild-type and efg1/efg1 cells: 696 to 597, 596 to 495, 496 to 388, 412 to 281, and 306 to 197. None of these ALS8 promoter fragments generated the Efg1-dependent complex (data not shown), unlike the E box region (196 to 106) (Fig. 5). The observation that the Efg1-dependent complex can form with cell extracts from yeast cells (Fig. 5A) and the observation that synthetic forms of Efg1 can interact directly with the E box (Fig. 4) suggest that this DNA binding activity is not dependent on activation of Efg1 by a morphogenetic stimulus.

Ernst (9) has pointed out that bHLH proteins can regulate genes that do not contain an E box. Also, we did not identify an E box in the 5' region of RBT1, which is regulated by Efg1 (3). It is conceivable that RBT1 is regulated indirectly by Efg1 or that Efg1 can bind sequences other than E boxes. Nevertheless, our data confirm that Efg1 is a sequence-specific DNA binding protein that is capable of binding the E box and that most hypha-specific genes contain E boxes in their promoters. This is consistent with the idea that Efg1 interacts directly with hypha-specific promoters in C. albicans to activate transcription of the promoters during hyphal development, and this has important implications for regulation of cellular morphogenesis in this human pathogen.

	ACKNOWLEDGMENTS

We thank Gerald Fink and Joachim Ernst for providing strains, Lois Hoyer for providing information about the ALS3 promoter, and Susan Budge for excellent technical assistance. We are grateful to the Stanford DNA Sequencing and Technology Center for access to their C. albicans genome sequence data (http://www-sequence.stanford.edu /group/candida), which were generated with the support of the NIDR and the Burroughs Wellcome Fund.

P.L. was supported by the UK Biotechnology and Biological Sciences Research Council (grants 1/CEL4563 and 97/B1/P/03008). P.R.L. and A.J.P.B. were supported by The Wellcome Trust (grants 041399, 055015, and 063204).

	FOOTNOTES

^* Corresponding author. Mailing address: Department of Molecular and Cell Biology, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, United Kingdom. Phone: 44-1224-273183. Fax: 44-1224-273144. E-mail: al.brown{at}abdn.ac.uk.

Present address: Division of Cellular & Molecular Biology, Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2M9, Canada.

Present address: Laboratory of Developmental Neurobiology, NICHD, National Institutes of Health, Bethesda, MD 20892-4480.

^§ Present address: Eye Research Institute of Canada, University of Toronto, Toronto, Ontario M5T 2S8, Canada.

	REFERENCES

Top Abstract Text References

1.	Bailey, D. A., P. J. F. Feldmann, M. Bovey, N. A. R. Gow, and A. J. P. Brown. 1996. The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J. Bacteriol. 178:5353-5360[Abstract/Free Full Text].
2.	Birse, C. E., M. Y. Irwin, W. A. Fonzi, and P. S. Sypherd. 1993. Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect. Immun. 61:3648-3655[Abstract/Free Full Text].
3.	Braun, B. R., and A. D. Johnson. 2000. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155:57-67[Abstract/Free Full Text].
4.	Braun, B. R., W. S. Head, M. X. Wang, and A. D. Johnson. 2000. Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics 156:31-44[Abstract/Free Full Text].
5.	Brown, A. J. P., and N. A. R. Gow. 1999. Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol. 7:333-338[CrossRef][Medline].
6.	Brown, D. H., A. D. Giusani, X. Chen, and C. A. Kumamoto. 1999. Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene. Mol. Microbiol. 34:651-662[CrossRef][Medline].
7.	Carey, J. 1991. Gel retardation. Methods Enzymol. 208:103-117[Medline].
8.	di Guan, C., P. Li, P. D. Riggs, and H. Inouye. 1987. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein. Gene 67:21-30.
9.	Ernst, J. F. 2000. Transcription factors in Candida albicansenvironmental control of morphogenesis. Microbiology 146:1763-1774[Free Full Text].
10.	Feng, Q., E. Summers, B. Guo, and G. Fink. 1999. Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. J. Bacteriol. 181:6339-6346[Abstract/Free Full Text].
11.	Gillum, A. M., E. Y. Tsay, and D. R. Kirsch. 1984. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182[CrossRef][Medline].
12.	Hoyer, L. L., T. L. Payne, M. Bell, A. M. Myers, and S. Scherer. 1998. Candida albicans ALS3 and insights into the nature of the ALS gene family. Curr. Genet. 33:451-459[CrossRef][Medline].
13.	Leberer, E., D. Harcus, I. D. Broadbent, K. L. Clark, D. Dignard, K. Ziegelbauer, A. Schmit, N. A. R. Gow, A. J. P. Brown, and D. Y. Thomas. 1996. Homologs of the Ste20p and Ste7p protein kinases are involved in hyphal formation of Candida albicans. Proc. Natl. Acad. Sci. USA 93:13217-13222[Abstract/Free Full Text].
14.	Leng, P. 1999. Gene regulation during morphogenesis in Candida albicans. Ph.D. thesis. University of Aberdeen, Aberdeen, United Kingdom.
15.	Liu, H., J. R. Kohler, and G. R. Fink. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266:1723-1726[Abstract/Free Full Text].
16.	Lo, H. J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949[CrossRef][Medline].
17.	Malathi, K., K. Ganesan, and A. Datta. 1994. Identification of a putative transcription factor in Candida albicans that can complement the mating defect of Saccharomyces cerevisiae ste12 mutants. J. Biol. Chem. 269:22945-22951[Abstract/Free Full Text].
18.	Massari, M. E., and C. Murre. 2000. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol. 20:429-440[Free Full Text].
19.	Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailliere Tindall, London, United Kingdom.
20.	Odds, F. C. 1994. Candida species and virulence. ASM News 60:313-318.
21.	Riggle, P. J., K. A. Anduitis, X. Chen, S. R. Tzipore, and C. A. Kamumoto. 1999. Invasive lesions containing filamentous forms produced by a Candida albicans mutant that is defective in filamentous growth in culture. Infect. Immun. 67:3649-3652[Abstract/Free Full Text].
22.	Robinson, K. A., and J. M. Lopes. 2000. Saccharomyces cerevisiae basic helix-loop-helix proteins regulate diverse biological processes. Nucleic Acids Res. 28:1499-1505[Abstract/Free Full Text].
23.	Sharkey, L. L., M. D. McNemar, S. M. Saporito-Irwin, P. S. Sypherd, and W. A. Fonzi. 1999. HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1 and RBF1. J. Bacteriol. 181:5273-5279[Abstract/Free Full Text].
24.	Sonneborn, A., D. P. Bockmuhl, M. Gerads, K. Kurpanek, D. Sanglard, and J. F. Ernst. 2000. Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans Mol. Microbiol. 35:386-396.
25.	Staab, J. F., C. A. Ferrer, and P. Sundstrom. 1996. Developmental expression of a tandemly repeated, proline and glutamine-rich amino acid motif on hyphal surfaces of Candida albicans. J. Biol. Chem. 271:6298-6305[Abstract/Free Full Text].
26.	Stoldt, V. R., A. Sonneborn, C. E. Leuker, and J. Ernst. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16:1982[CrossRef][Medline].
27.	van Helden, J., B. André, and J. Collado-Vides. 2000. A web site for the computational analysis of yeast regulatory sequences. Yeast 16:177-187[CrossRef][Medline].

This article has been cited by other articles:

• Noffz, C. S., Liedschulte, V., Lengeler, K., Ernst, J. F. (2008). Functional Mapping of the Candida albicans Efg1 Regulator. Eukaryot Cell 7: 881-893 [Abstract] [Full Text]  
• Biswas, S., Van Dijck, P., Datta, A. (2007). Environmental Sensing and Signal Transduction Pathways Regulating Morphopathogenic Determinants of Candida albicans. Microbiol. Mol. Biol. Rev. 71: 348-376 [Abstract] [Full Text]  
• Argimon, S., Wishart, J. A., Leng, R., Macaskill, S., Mavor, A., Alexandris, T., Nicholls, S., Knight, A. W., Enjalbert, B., Walmsley, R., Odds, F. C., Gow, N. A. R., Brown, A. J. P. (2007). Developmental Regulation of an Adhesin Gene during Cellular Morphogenesis in the Fungal Pathogen Candida albicans. Eukaryot Cell 6: 682-692 [Abstract] [Full Text]  
• Zhao, X., Daniels, K. J., Oh, S.-H., Green, C. B., Yeater, K. M., Soll, D. R., Hoyer, L. L. (2006). Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces.. Microbiology 152: 2287-2299 [Abstract] [Full Text]  
• Vinces, M. D., Haas, C., Kumamoto, C. A. (2006). Expression of the Candida albicans Morphogenesis Regulator Gene CZF1 and Its Regulation by Efg1p and Czf1p. Eukaryot Cell 5: 825-835 [Abstract] [Full Text]  
• Sohn, K., Roehm, M., Urban, C., Saunders, N., Rothenstein, D., Lottspeich, F., Schroppel, K., Brunner, H., Rupp, S. (2005). Identification and Characterization of Cor33p, a Novel Protein Implicated in Tolerance towards Oxidative Stress in Candida albicans. Eukaryot Cell 4: 2160-2169 [Abstract] [Full Text]  
• Zhao, X., Oh, S.-H., Cheng, G., Green, C. B., Nuessen, J. A., Yeater, K., Leng, R. P., Brown, A. J. P., Hoyer, L. L. (2004). ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. Microbiology 150: 2415-2428 [Abstract] [Full Text]  
• Doedt, T., Krishnamurthy, S., Bockmuhl, D. P., Tebarth, B., Stempel, C., Russell, C. L., Brown, A. J.P., Ernst, J. F. (2004). APSES Proteins Regulate Morphogenesis and Metabolism in Candida albicans. Mol. Biol. Cell 15: 3167-3180 [Abstract] [Full Text]  
• Staib, P., Binder, A., Kretschmar, M., Nichterlein, T., Schroppel, K., Morschhauser, J. (2004). Tec1p-Independent Activation of a Hypha-Associated Candida albicans Virulence Gene during Infection. Infect. Immun. 72: 2386-2389 [Abstract] [Full Text]  
• Martchenko, M., Alarco, A.-M., Harcus, D., Whiteway, M. (2004). Superoxide Dismutases in Candida albicans: Transcriptional Regulation and Functional Characterization of the Hyphal-induced SOD5 Gene. Mol. Biol. Cell 15: 456-467 [Abstract] [Full Text]  
• Li, F., Palecek, S. P. (2003). EAP1, a Candida albicans Gene Involved in Binding Human Epithelial Cells. Eukaryot Cell 2: 1266-1273 [Abstract] [Full Text]  
• Biswas, S., Roy, M., Datta, A. (2003). N-Acetylglucosamine-inducible CaGAP1 encodes a general amino acid permease which co-ordinates external nitrogen source response and morphogenesis in Candida albicans. Microbiology 149: 2597-2608 [Abstract] [Full Text]  
• Santos, R., Buisson, N., Knight, S., Dancis, A., Camadro, J.-M., Lesuisse, E. (2003). Haemin uptake and use as an iron source by Candida albicans: role of CaHMX1-encoded haem oxygenase. Microbiology 149: 579-588 [Abstract] [Full Text]  
• Giusani, A. D., Vinces, M., Kumamoto, C. A. (2002). Invasive Filamentous Growth of Candida albicans Is Promoted by Czf1p-Dependent Relief of Efg1p-Mediated Repression. Genetics 160: 1749-1753 [Abstract] [Full Text]  
• Lane, S., Birse, C., Zhou, S., Matson, R., Liu, H. (2001). DNA Array Studies Demonstrate Convergent Regulation of Virulence Factors by Cph1, Cph2, and Efg1 in Candida albicans. J. Biol. Chem. 276: 48988-48996 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leng, P. Articles by Brown, A. J. P. Search for Related Content PubMed PubMed Citation Articles by Leng, P. Articles by Brown, A. J. P.